CARLSMED, INC.

CARL· Nasdaq· Surgical & Medical Instruments & Apparatus

Market cap
–
P/FCF
–
EV/Sales
–
FCF margin
-58.6%
ROIC, 5 yr avg
–
Revenue, 5 yr CAGR
–
We record prices for the companies we cover; CARL is not one of them yet.

Company statistics

From the 10-Ks, computed in code · point at a figure for its formula

Profile · FY2025

Market cap
–
Enterprise value
–
Diluted shares
14.2M
Revenue
$50.5M
Free cash flow
-$29.6M
Owner earnings
-$31.5M

Valuation · FY2025

P/E
–
P/FCF
–
P/Owner earnings
–
EV/Sales
–
EV/FCF
–
P/B
–

Margins · FY2025

Gross
75.3%
Operating
-60.5%
Net
-58.7%
Free cash flow
-58.6%
Owner earnings
-62.5%
Stock pay
3.8%

Returns

ROIC, FY2025
–
ROIC, 5 yr avg
–
ROE, FY2025
-30.0%
ROE, 5 yr avg
–

Growth (CAGR)

Revenue, 3 yr
–
Revenue, 5 yr
–
Revenue, 1 yr
85.9%
Diluted EPS, 3 yr
–
Diluted EPS, 5 yr
–
Diluted EPS, 1 yr
–
Free cash flow, 3 yr
–
Free cash flow, 5 yr
–
Free cash flow, 1 yr
–

Financial health · FY2025

Cash and investments
$109.8M
Total debt
$15.3M
Net cash
$94.4M
Debt/Equity
0.2x
Debt/FCF
–

Shareholder returns · FY2025

Dividend yield
–
Payout ratio
–
Buyback yield
–
Shareholder yield
–
Share count, 5 yr
–

Financials: ten years from the 10-Ks

Reported numbers open their filing · computed ones show the formula · ˢ split-adjusted

Every figure, year by year

Fiscal yearFY2024FY2025
The business
Revenue$27.2M$50.5M
Revenue growth–85.9%
Gross margin73.8%75.3%
Operating margin-88.8%-60.5%
Net income-$24.3M-$29.6M
Net margin-89.3%-58.7%
Diluted EPS$-6.11$-2.12
Return on invested capital?––
Cash
Operating cash flow-$25.5M-$29.0M
Capital expenditure$180.0K$642.0K
Free cash flow-$25.6M-$29.6M
Stock-based compensation$253.0K$1.9M
Owner earnings?-$25.9M-$31.5M
Free cash flow per share$-6.31$-2.08
Capital allocation
Dividends paid––
Share repurchases––
Diluted shares4.1M14.2M
Share count change?–249.7%
Balance sheet
Cash and equivalents$40.1M$85.8M
Short-term investments$0$24.0M
Total debt$15.4M$15.3M
Net debt-$24.7M-$94.4M
Shareholders' equity-$70.6M$98.9M

Latest filings

All on EDGAR
2026-08-0510-QQuarterly report
2026-08-058-KEarnings release
2026-05-0510-QQuarterly report
2026-05-058-KEarnings release
2026-04-22DEF 14AProxy statement
2026-02-2510-KAnnual report
2026-02-258-KEarnings release
2026-01-128-KEarnings release
2025-11-0610-QQuarterly report
2025-11-068-KEarnings release

More from our coverage

All coverage